Overview Financials News + Filings Key Docs Charts Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Director departure
Quarterly results
|
|
MusclePharm Corp (MSLP)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 07/19/2023 |
8-K
| Quarterly results |
| 03/10/2023 |
8-K
| Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements... |
| 01/11/2023 |
8-K
| Quarterly results |
| 01/10/2023 |
8-K
| Changes in Registrant's Certifying Accountant |
| 01/09/2023 |
8-K
| Quarterly results |
| 12/21/2022 |
SC 13D/A
| Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] |
| 09/29/2022 |
8-K
| Quarterly results |
| 08/23/2022 |
8-K
| Quarterly results |
| 08/22/2022 |
8-K
| Quarterly results |
| 08/16/2022 |
NT 10-Q
| Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB: |
| 07/28/2022 |
8-K
| Quarterly results |
| 07/28/2022 |
4
| Rizvi Sabina (President & CFO) has filed a Form 4 on MusclePharm Corp|
Txns:
| Granted 1,811,000 options to buy
@ $0.4, valued at
$724.4k
|
|
| 07/28/2022 |
3
| Rizvi Sabina (President & CFO) has filed a Form 3 on MusclePharm Corp |
| 07/12/2022 |
8-K
| Quarterly results |
| 06/22/2022 |
3
| Chin Eric (Chief Accounting Officer) has filed a Form 3 on MusclePharm Corp |
| 06/22/2022 |
8-K
| Quarterly results |
| 06/16/2022 |
S-1
| Form S-1 - General form for registration of securities under the Securities Act of 1933: |
| 06/14/2022 |
8-K
| Quarterly results |
| 06/09/2022 |
8-K
| Quarterly results |
| 05/17/2022 |
8-K
| Quarterly results |
| 05/16/2022 |
10-Q
| Quarterly Report for the period ended March 31, 2022 |
| 05/05/2022 |
8-K
| Quarterly results |
| 05/04/2022 |
10-K/A
| Annual Report for the period ended December 31, 2021 [amend] |
| 04/28/2022 |
8-K
| Quarterly results |
| 04/15/2022 |
10-K
| Annual Report for the period ended December 31, 2021 |
| 04/01/2022 |
SC 13D/A
| White Winston Select Asset Fund Series Fund MP-18, LLC reports a 9% stake in MusclePharm Corporation |
| 03/31/2022 |
4
| White Winston Select Asset Fund Series Fund MP-18, LLC (10% Owner) has filed a Form 4 on MusclePharm Corp|
Txns:
| Sold 626,826 shares
@ $0 |
|
| 03/31/2022 |
NT 10-K
| Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405: |
| 03/11/2022 |
8-K
| Quarterly results |
| 02/22/2022 |
SC 13D/A
| White Winston Select Asset Fund Series Fund MP-18, LLC reports a 10.9% stake in MusclePharm Corporation |
| 12/29/2021 |
8-K
| Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements... |
| 11/17/2021 |
10-Q
| Quarterly Report for the period ended September 30, 2021 |
| 11/15/2021 |
8-K
| Quarterly results|
Docs:
|
"Three Months Ended September 30, Nine Months Ended September 30, 2021 2020 2021 2020 Revenue, net $ 11,971 $ 16,085 $ 40,000 $ 49,309 Cost of revenue 11,942 11,073 34,102 34,504 Gross profit 29 5,012 5,898 14,805 Operating expenses: General and administration 2,453 3,586 7,609 11,001 Selling and promotion 1,012 623 3,195 2,100 Impairment of intangible assets - 167 - 167 Total operating expenses 3,465 4,376 10,804 13,268 Income from operations 636 1,537 Other income: Loss on settlement obligation" |
|
| 11/02/2021 |
8-K
| Entry into a Material Definitive Agreement, Regulation FD Disclosure, Financial Statements and Exhibits Inte... |
|
|
|